tecvayli
janssen-cilag international n.v. - teclistamab - mitu müeloomit - antineoplastilised ained - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
talvey
janssen-cilag international n.v. - talquetamab - mitu müeloomit - antineoplastilised ained - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuuria, paroksüsmaalne - immunosupressandid - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
jaypirca
eli lilly nederland b.v. - pirtobrutinib - lümfoom, mantle-cell - protein kinase inhibiitorid - treatment of mantle cell lymphoma (mcl).
resflor süstelahus
intervet international b.v. - florfenikool+fluniksiin - süstelahus - 300mg+16,5mg 1ml 100ml 1tk; 300mg+16,5mg 1ml 250ml 1tk
tuloxxin süstelahus
krka d.d. novo mesto - tulatromütsiin - süstelahus - 100mg 1ml 100ml 1tk; 100mg 1ml 250ml 1tk
levatum super süstelahus
chanelle animal health ltd - ivermektiin+klorsuloon - süstelahus - 10mg+100mg 1ml 50ml 1tk; 10mg+100mg 1ml 500ml 1tk; 10mg+100mg 1ml 250ml 1tk
tulaject süstelahus
alivira animal health limited - tulatromütsiin - süstelahus - 100mg 1ml 250ml 1tk
myfortic gastroresistentne tablett
novartis baltics sia - mükofenoolhape - gastroresistentne tablett - 360mg 50tk; 360mg 120tk; 360mg 250tk
agil® 100 ec
adama - emulsioonikontsentraat - propakvisafop - herbitsiidid